S&CO Inc’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.53M | Hold |
81,497
| – | – | 0.4% | 56 |
|
|
2025
Q4 | $6.95M | Hold |
81,497
| – | – | 0.43% | 52 |
|
|
2025
Q3 | $6.34M | Sell |
81,497
-650
| -0.8% | -$50.8K | 0.39% | 55 |
|
|
2025
Q2 | $6.42M | Sell |
82,147
-650
| -0.8% | -$48.5K | 0.41% | 56 |
|
|
2025
Q1 | $6M | Buy |
82,797
+21,115
| +34% | +$1.51M | 0.4% | 57 |
|
|
2024
Q4 | $4.57M | Buy |
61,682
+127
| +0.2% | +$8.89K | 0.31% | 72 |
|
|
2024
Q3 | $4.06M | Buy |
61,555
+12,120
| +25% | +$881K | 0.27% | 76 |
|
|
2024
Q2 | $4.57M | Sell |
49,435
-100
| -0.2% | -$8.86K | 0.32% | 67 |
|
|
2024
Q1 | $4.73M | Buy |
49,535
+8,000
| +19% | +$672K | 0.33% | 65 |
|
|
2023
Q4 | $3.17M | Buy |
41,535
+5,155
| +14% | +$359K | 0.24% | 77 |
|
|
2023
Q3 | $2.52M | Hold |
36,380
| – | – | 0.21% | 77 |
|
|
2023
Q2 | $3.43M | Hold |
36,380
| – | – | 0.28% | 69 |
|
|
2023
Q1 | $3.01M | Hold |
36,380
| – | – | 0.26% | 69 |
|
|
2022
Q4 | $2.71M | Hold |
36,380
| – | – | 0.24% | 72 |
|
|
2022
Q3 | $3.01M | Hold |
36,380
| – | – | 0.27% | 68 |
|
|
2022
Q2 | $3.46M | Sell |
36,380
-470
| -1% | -$48.7K | 0.29% | 63 |
|
|
2022
Q1 | $4.34M | Buy |
36,850
+11,250
| +44% | +$1.26M | 0.3% | 64 |
|
|
2021
Q4 | $3.32M | Buy |
25,600
+15,000
| +142% | +$1.75M | 0.23% | 77 |
|
|
2021
Q3 | $1.2M | Hold |
10,600
| – | – | 0.09% | 115 |
|
|
2021
Q2 | $1.1M | Hold |
10,600
| – | – | 0.09% | 120 |
|
|
2021
Q1 | $886K | Hold |
10,600
| – | – | 0.07% | 128 |
|
|
2020
Q4 | $967K | Hold |
10,600
| – | – | 0.09% | 119 |
|
|
2020
Q3 | $846K | Sell |
10,600
-2,000
| -16% | -$156K | 0.08% | 120 |
|
|
2020
Q2 | $871K | Hold |
12,600
| – | – | 0.1% | 113 |
|
|
2020
Q1 | $792K | Hold |
12,600
| – | – | 0.11% | 111 |
|
|
2019
Q4 | $980K | Sell |
12,600
-3,900
| -24% | -$305K | 0.1% | 108 |
|
|
2019
Q3 | $1.21M | Hold |
16,500
| – | – | 0.13% | 96 |
|
|
2019
Q2 | $1.02M | Hold |
16,500
| – | – | 0.11% | 107 |
|
|
2019
Q1 | $1.05M | Hold |
16,500
| – | – | 0.12% | 106 |
|
|
2018
Q4 | $842K | Hold |
16,500
| – | – | 0.11% | 111 |
|
|
2018
Q3 | $958K | Sell |
16,500
-1,500
| -8% | -$73.4K | 0.11% | 113 |
|
|
2018
Q2 | $873K | Hold |
18,000
| – | – | 0.11% | 114 |
|
|
2018
Q1 | $837K | Hold |
18,000
| – | – | 0.11% | 108 |
|
|
2017
Q4 | $676K | Hold |
18,000
| – | – | 0.08% | 115 |
|
|
2017
Q3 | $656K | Hold |
18,000
| – | – | 0.08% | 115 |
|
|
2017
Q2 | $709K | Hold |
18,000
| – | – | 0.09% | 111 |
|
|
2017
Q1 | $564K | Buy |
+18,000
| New | +$564K | 0.08% | 116 |
|
Other funds holding EW
VCM
VPM
S&CO Inc's EW Position: Q1 2026 in Review
S&CO Inc held its Edwards Lifesciences (EW) position steady in Q1 2026 at 81,497 shares worth $6.53M. The position accounts for 0.4% of the portfolio, ranked #56.
S&CO Inc first reported a position in EW in Q1 2017 and has held it in 37 quarters since. The position peaked at $6.95M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- S&CO Inc held 81,497 shares of Edwards Lifesciences worth $6.53M as of Q1 2026.
- S&CO Inc left its Edwards Lifesciences share count unchanged in Q1 2026.
- Edwards Lifesciences made up 0.4% of S&CO Inc's portfolio in Q1 2026, its #56 holding.
- S&CO Inc first reported a position in Edwards Lifesciences in Q1 2017 and has held it in 37 quarters since.
- S&CO Inc's Edwards Lifesciences position peaked at $6.95M in Q4 2025.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on S&CO Inc's 13F filing for Q1 2026, filed 7 May 2026.